Vimarsana
Biggest News Aggregation in the World

Page 6 - Matt Pullen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Matt Pullen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Matt Pullen Today - Breaking & Trending Today

The IT Pro Podcast: Making data centres green again - Vimarsana News

The IT Pro Podcast: Making data centres green again

How can data centre operators help lessen their impact on climate change?

Related Topics:
United KingdomMatt Pullen
Owen Sound-area toy drive organizers expecting increased need - Vimarsana News

Owen Sound-area toy drive organizers expecting increased need

With Christmas just over a month away, local toy drives have kicked off and early indications are that the need in the Owen Sound area is as high as it has…

Owen Sound-area toy drive organizers expecting increased need - Vimarsana News

Owen Sound-area toy drive organizers expecting increased need

With Christmas just over a month away, local toy drives have kicked off and early indications are that the need in the Owen Sound area is as high as it has…

Nationwide COVID-OUT treatment trial with ivermectin is underway - Vimarsana News

Nationwide COVID-OUT treatment trial with ivermectin is underway

Nationwide COVID-OUT treatment trial with ivermectin is underway Phoenix Herald 23 Jul 2021, 10 GMT+10 An ongoing COVID-19 clinical trial studying the outpatient use of metformin, a generic medication for type 2 diabetes, has expanded and will now be the nation's first to include fluvoxamine, an antidepressant, and ivermectin, an antiparasitic, as possible treatment options to prevent hospitalization and "long COVID." Led by the University of Minnesota Medical School, the multi-site clinical trial received new support $1 million from the Rainwater Charitable Foundation and $500,000 from Fast ...

U of M Medical School receives $1.5M for nation's first ivermectin COVID-19 clinical trial - Vimarsana News

U of M Medical School receives $1.5M for nation's first ivermectin COVID-19 clinical trial

 E-Mail MINNEAPOLIS/ST. PAUL (05/25/2021) -- An ongoing COVID-19 clinical trial studying the outpatient use of metformin, a generic medication for type 2 diabetes, has expanded and will now be the nation's first to include fluvoxamine, an antidepressant, and ivermectin, an antiparasitic, as possible treatment options to prevent hospitalization and "long COVID." Led by the University of Minnesota Medical School, the multi-site clinical trial received new support - $1 million from the Rainwater Charitable Foundation and $500,000 from Fast Grants - to expand the study, which is also the first r...